This website uses cookies. By continuing to browse this website you are agreeing to our use of cookies. Find out more by reading our privacy policy. Read more
Novo Nordisk A/S : Novo Nordisk A/S purchases B shares worth DKK 4.2 billion from Novo A/S as part of the ongoing share repurchase programme (2 May 2012)
| Read the full announcement in PDF format |
Novo Nordisk A/S has today entered into an agreement to purchase 5,100,000 B shares (nominal DKK 1) of a value of DKK 4.2 billion from Novo A/S as part of the ongoing DKK 12.0 billion share repurchase programme for a 12 month period beginning 2 February 2012. The transaction price is set to DKK 823.11 per share and has been calculated as the average market price from 27 April to 1 May in the open trading window following the announcement of Novo Nordisk's financial results for the first quarter of 2012.
Further information on Novo Nordisk A/S please contact:
| Media: | Investors: |
| Outside North America: | Kasper Roseeuw Poulsen |
| Anne Margrethe Hauge | Tel: (+45) 4442 4303 |
| Tel: (+45) 4442 3450 | krop@novonordisk.com |
| amhg@novonordisk.com | |
| Frank Daniel Mersebach | |
| Tel: (+45) 4442 0604 | |
| fdni@novonordisk.com | |
| Lars Borup Jacobsen | |
| Tel: (+45) 3075 3479 | |
| lbpj@novonordisk.com | |
| In North America: | |
| Ken Inchausti | Jannick Lindegaard |
| Tel: (+1) 609 514 8316 | Tel: (+1) 609 786 4575 |
| kiau@novonordisk.com | jlis@novonordisk.com |
Further information on Novo A/S please contact:
Media:
Henrik Gürtler, CEO
Tel: (+45) 3527 6575
Thorkil Kastberg Christensen, CFO
Tel: (+45) 3527 6592
Company Announcement No 31 / 2012
